Loading stock data...

Syschem (India) Limited

BSE: SYSCHEM

BSE
55.79 3.55 (6.80%)

Prev Close

52.24

Open Price

53

Volume

490,000

Today Low / High

50.72 / 57.9

52 WK Low / High

35.33 / 57.9

Range

53 - 59

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 55.79, reflecting a change of 3.55 (6.79556%). The expected target range on the BSE is 53 - 59. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

22 Aug 53.00 5.26%
21 Aug 46.80 11.62%
20 Aug 47.50 -3.26%
19 Aug 48.00 -3.13%
18 Aug 47.80 -1.30%
14 Aug 45.40 2.53%
13 Aug 45.00 4.38%
12 Aug 46.00 -0.89%
11 Aug 46.10 -1.37%
08 Aug 46.40 -3.06%
07 Aug 45.80 -0.39%
06 Aug 46.24 -1.23%
05 Aug 45.85 -0.20%
04 Aug 45.05 -2.29%
01 Aug 44.00 1.57%
31 Jul 44.70 -0.40%
30 Jul 46.64 -5.15%
29 Jul 46.50 -1.40%
28 Jul 45.83 -0.85%

Syschem (India) Limited Graph

Syschem (India) Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Syschem (India) Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 55.79, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 55.79 56.35 50.71 - 61.98
56.91 45.52 - 68.29
57.46 40.22 - 74.70
Bearish Scenario 55.79 55.23 49.71 - 60.76
54.67 43.74 - 65.61
54.12 37.88 - 70.35

Overview of Syschem (India) Limited

ISIN

INE121D01036

Industry

Medical - Pharmaceuticals

Vol.Avg

44,454

Market Cap

2,427,590,270

Last Dividend

0

Official Website

Visit Website

IPO Date

2003-01-15

DCF Diff

80.97

DCF

-24

Financial Ratios Every Investor Needs

Stock Rating Details for SYSCHEM

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 386.23 Cr 307.22 Cr 79.01 Cr 0.2046 0.00 Cr 0.00 Cr 70.76 Cr 0.46 Cr 0.12 3.98 Cr 0.0012
2024-03-31 233.53 Cr 176.63 Cr 56.90 Cr 0.2437 0.00 Cr 6.26 Cr 50.49 Cr 2.76 Cr 0.78 7.11 Cr 0.0118
2023-03-31 113.45 Cr 98.67 Cr 14.78 Cr 0.1303 0.00 Cr 0.75 Cr 5.94 Cr 4.51 Cr 1.41 8.85 Cr 0.0398
2022-03-31 58.86 Cr 51.93 Cr 6.93 Cr 0.1178 0.00 Cr 0.83 Cr -1.90 Cr -1.71 Cr -0.69 0.69 Cr -0.0290
2021-03-31 68.18 Cr 66.65 Cr 1.53 Cr 0.0225 0.00 Cr 1.10 Cr -7.17 Cr -5.57 Cr -2.48 -4.90 Cr -0.0816

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 2.14 Cr 217.26 Cr 125.97 Cr 91.2879 Cr 0.00 Cr -2.14 Cr 68.28 Cr 53.40 Cr 0.00 Cr 0.00 Cr 0.00 Cr 124.0540 Cr
2024-03-31 0.10 Cr 164.03 Cr 107.07 Cr 56.9564 Cr 0.45 Cr 0.35 Cr 51.40 Cr 34.67 Cr 0.00 Cr 0.00 Cr 0.00 Cr 96.7717 Cr
2023-03-31 0.57 Cr 92.71 Cr 70.41 Cr 22.3046 Cr 1.61 Cr 1.03 Cr 15.52 Cr 30.80 Cr 0.00 Cr 0.00 Cr 0.00 Cr 42.9751 Cr
2022-03-31 0.03 Cr 59.81 Cr 52.87 Cr 6.9416 Cr 1.75 Cr 1.72 Cr 19.14 Cr 31.48 Cr 0.00 Cr 0.00 Cr 0.00 Cr 25.5402 Cr
2021-03-31 0.02 Cr 77.17 Cr 70.05 Cr 7.1238 Cr 15.22 Cr 15.19 Cr 33.26 Cr 30.55 Cr 1.40 Cr 0.00 Cr 0.00 Cr 40.8907 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -10.0938 Cr -21.6707 Cr 33.8053 Cr -31.8130 Cr 2.0408 Cr 2.1365 Cr -21.7192 Cr 0.4601 Cr 0.0000 Cr 0.0000 Cr -16.8816 Cr
2024-03-31 -25.6481 Cr -6.4649 Cr 31.6378 Cr -32.3305 Cr -0.4752 Cr 0.0957 Cr -6.6824 Cr 2.7614 Cr 0.0000 Cr 0.0000 Cr -35.8788 Cr
2023-03-31 -8.4950 Cr 9.0805 Cr -0.0421 Cr -10.4531 Cr 0.5435 Cr 0.5709 Cr -1.9581 Cr 6.1507 Cr 0.0000 Cr 0.0000 Cr 3.6192 Cr
2022-03-31 1.0699 Cr -0.7824 Cr -0.2842 Cr -3.3432 Cr 0.0033 Cr 0.0274 Cr -4.4131 Cr -2.1732 Cr 0.0000 Cr 0.0000 Cr 14.1227 Cr
2021-03-31 3.7181 Cr -3.7743 Cr -0.0554 Cr -1.3905 Cr -0.1114 Cr 0.0241 Cr -5.1086 Cr -7.3149 Cr 0.0000 Cr 0.0000 Cr -12.7331 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 109.32 Cr 103.59 Cr 5.73 Cr 0.0524 1.71 Cr 1.67 Cr 0.38 2.47 Cr 0.0153
2025-03-31 118.87 Cr 107.44 Cr 31.31 Cr 0.2634 29.06 Cr 0.46 Cr 0.11 1.73 Cr 0.0039
2024-12-31 77.76 Cr 72.80 Cr 4.97 Cr 0.0639 0.52 Cr 0.50 Cr 0.13 1.22 Cr 0.0065
2024-09-30 47.52 Cr 43.50 Cr 4.02 Cr 0.0847 -0.61 Cr -0.64 Cr -0.16 0.07 Cr -0.0135
2024-06-30 87.53 Cr 86.06 Cr 1.47 Cr 0.0168 0.13 Cr 0.14 Cr 0.03 0.82 Cr 0.0016

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 2.14 Cr 0.00 Cr 2.14 Cr 89.54 Cr 68.28 Cr 161.43 Cr 53.40 Cr 217.26 Cr 125.97 Cr
2024-12-31 0.00 Cr 0.00 Cr 0.10 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -56.45 Cr
2024-09-30 0.09 Cr 0.01 Cr 0.10 Cr 32.53 Cr 31.72 Cr 65.00 Cr 49.18 Cr 117.18 Cr 60.73 Cr
2024-06-30 0.00 Cr 0.00 Cr 0.10 Cr 0.00 Cr 0.00 Cr 0.10 Cr 0.00 Cr 0.00 Cr -56.96 Cr
2024-03-31 0.10 Cr 0.00 Cr 0.10 Cr 68.43 Cr 51.40 Cr 126.35 Cr 34.67 Cr 164.03 Cr 107.07 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 0.46 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 0.50 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 -0.64 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.14 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 -0.26 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2023-09-28 September 28, 23 136:125
2015-01-19 January 19, 15 1:10
2014-12-12 December 12, 14 1:10
2003-04-22 April 22, 03 10:1

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹821.25 ₹98,339,283,675.00 ₹72,992.00

Key Executives

Company Secretary & Compliance Officer
Ms. Shikha Kataria B.Com., C.S., L.L.B.

Gender: female

Year Born:

Non-Executive Non-Independent Director
Mr. Sunil Kumar Bhasin

Gender: male

Year Born:

MD & Director
Mr. Ranjan Jain

Gender: male

Year Born: 1966

Chief Financial Officer
Mr. Sanjeev Agrawal

Gender: male

Year Born:

Whole-Time Director
Mr. Suninder Veer Singh

Gender: male

Year Born: 1974

FAQs about Syschem (India) Limited

Who is the CEO of the company?

The CEO is Ranjan Jain.

What is the current market price of the stock?

The current price is ₹55.79.

What is the 52-week price range?

The range is ₹35.33-57.9.

What is the market capitalization of the company?

The market capitalization is ₹242.76 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 123.04.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Syschem (India) Limited (ISIN: INE121D01036) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹242.76 crores and an average daily volume of 44,454 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack